← Back to Search

Air Leak Management for Pneumothorax (CT0128 Trial)

N/A
Recruiting
Led By Moishe Liberman, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 months
Awards & highlights

CT0128 Trial Summary

This trial tests a method to detect, reduce and treat air leaks during surgery, potentially reducing complications, morbidity and hospital stays for lung surgery.

Who is the study for?
This trial is for patients undergoing lung transplant surgery who cannot donate their lungs. It's not open to healthy individuals.Check my eligibility
What is being tested?
The study aims to develop a method to detect, measure, and treat air leaks during surgery using a bio-adhesive. This could reduce complications and hospital stays after lung surgeries.See study design
What are the potential side effects?
Potential side effects may include reactions to the bio-adhesive such as inflammation or infection at the application site, but specific side effects will depend on individual patient responses.

CT0128 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Detection and localisation of air leaks in deflated lungs using condensed air through the airway. Changing the size (ml) of air leaks by 80% by the use of a novel bio sealant directly on the lung parenchyma.
Secondary outcome measures
Establishing a standardized measure to localize air leaks in a physiological setting.
Quantify and treat air leaks in a physiological setting

CT0128 Trial Design

1Treatment groups
Experimental Treatment
Group I: Air LeaksExperimental Treatment1 Intervention
Lungs from patients undergoing lung transplantation after their removal from the recipient patient with previous informed consent signed before transplantation will be obtained. The organs will be placed in an acrylic box and will be kept at a temperature of 37 Celsius degrees. In order to reproduce intraoperative air leaks, various manipulations, including stapling and creating lacerations of different depts and lengths on the parenchyma, will be performed on deflated lungs. Following the introduction of a leak, condensed gas will be pushed through the airway to precisely localize the defect. The sealant prepared at room temperature will then be applied in a thin layer to cover the defect and will be left to dry for 5 minutes. The seal will be tested using the condensed gas with the lung still deflated as well as with the water immersion technique after inflating the lung.

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,437 Total Patients Enrolled
Moishe Liberman, MDPrincipal InvestigatorCHUM
3 Previous Clinical Trials
365 Total Patients Enrolled

Media Library

Air Leaks Clinical Trial Eligibility Overview. Trial Name: NCT05854654 — N/A
Pneumothorax Research Study Groups: Air Leaks
Pneumothorax Clinical Trial 2023: Air Leaks Highlights & Side Effects. Trial Name: NCT05854654 — N/A
Air Leaks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05854654 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this investigative procedure currently underway?

"Clinicaltrials.gov informs us that this particular trial is not presently enrolling participants, having first been posted on the 30th of May in 2023 and last updated on 2nd of the same month. Nevertheless, there are 1 other studies currently recruiting patients."

Answered by AI
~133 spots leftby Apr 2027